How genomics is changing our view of cancer

被引：0
作者：
Loots, Gabriela G. [1 ]
机构：
[1] Lawrence Livermore Natl Lab, Biol & Biotechnol Div, Livermore, CA 94550 USA
来源：
BRIEFINGS IN FUNCTIONAL GENOMICS | 2013年 / 12卷 / 05期
关键词：
D O I：
10.1093/bfgp/elt035
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：389 / 390
页数：2
相关论文
共 6 条
[1]  
Cushman-Vokoun AM, 2013, CLIN COLORECTAL CANC
[2]  
De P, 2013, CANC TREAT REV
[3]  
Gailhouste L, 2013, FRONT BIOSCI
[4]   Cancer treatment according to BRCA1 and BRCA2 mutations [J].
Maxwell, Kara N. ;
Domchek, Susan M. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2012, 9 (09) :520-528
[5]   Simultaneous detection of TOP2A and HER2 gene amplification by multiplex ligation-dependent probe amplification in breast cancer [J].
Moelans, Cathy B. ;
de Weger, Roel A. ;
van Blokland, Marja T. M. ;
van der Wall, Elsken ;
van Diest, Paul J. .
MODERN PATHOLOGY, 2010, 23 (01) :62-70
[6]   The Prognostic Role of BRAF Mutation in Metastatic Colorectal Cancer Receiving Anti-EGFR Monoclonal Antibodies: A Meta-Analysis [J].
Yuan, Zi-Xu ;
Wang, Xiao-Yan ;
Qin, Qi-Yuan ;
Chen, De-Feng ;
Zhong, Qing-Hua ;
Wang, Lei ;
Wang, Jian-Ping .
PLOS ONE, 2013, 8 (06)
1